BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35119769)

  • 21. Comparative Effectiveness of Statin Therapy in Chronic Kidney Disease and Acute Myocardial Infarction: A Retrospective Cohort Study.
    Smith DH; Johnson ES; Boudreau DM; Cassidy-Bushrow AE; Fortmann SP; Greenlee RT; Gurwitz JH; Magid DJ; McNeal CJ; Reynolds K; Steinhubl SR; Thorp M; Tom JO; Vupputuri S; VanWormer JJ; Weinstein J; Yang X; Go AS; Sidney S
    Am J Med; 2015 Nov; 128(11):1252.e1-1252.e11. PubMed ID: 26169887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study.
    Oza A; Lu N; Schoenfeld SR; Fisher MC; Dubreuil M; Rai SK; Zhang Y; Choi HK
    Ann Rheum Dis; 2017 Oct; 76(10):1737-1742. PubMed ID: 28698231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low utilization of statins in patients with dermatomyositis/polymyositis and hyperlipidemia: a multicenter USA-based study (2013-2023).
    Fares J; Summer R; Loizidis G
    Clin Rheumatol; 2024 Jan; 43(1):325-338. PubMed ID: 37930595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Thiazide Diuretics With Diabetes Progression, Kidney Disease Progression, Cardiovascular Outcomes, and Death Among Patients With Diabetes Who Initiate Statins.
    Afify H; Gonzalez-Morales U; Asmar A; Alvarez CA; Mansi IA
    Am J Cardiol; 2023 Sep; 203():274-284. PubMed ID: 37516035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statin use and risk of joint replacement due to osteoarthritis and rheumatoid arthritis: a propensity-score matched longitudinal cohort study.
    Sarmanova A; Doherty M; Kuo C; Wei J; Abhishek A; Mallen C; Zeng C; Wang Y; Lei G; Zhang W
    Rheumatology (Oxford); 2020 Oct; 59(10):2898-2907. PubMed ID: 32097491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin use and mortality in gout: A general population-based cohort study.
    Keller SF; Rai SK; Lu N; Oza A; Jorge AM; Zhang Y; Choi HK
    Semin Arthritis Rheum; 2018 Dec; 48(3):449-455. PubMed ID: 29801703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study.
    Kim SC; Solomon DH; Rogers JR; Gale S; Klearman M; Sarsour K; Schneeweiss S
    Arthritis Rheumatol; 2017 Jun; 69(6):1154-1164. PubMed ID: 28245350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of statins on coronary atherosclerosis progression and long-term cardiovascular disease risk in rheumatoid arthritis.
    Karpouzas GA; Ormseth SR; Hernandez E; Budoff MJ
    Rheumatology (Oxford); 2022 May; 61(5):1857-1866. PubMed ID: 34373923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New statin use, mortality, and first cardiovascular events in older US Veterans by frailty status.
    Orkaby AR; Lu B; Ho YL; Treu T; Galloway A; Wilson PWF; Cho K; Gaziano JM; Alexander KP; Gagnon DR; Djousse L; Forman DE; Driver JA
    J Am Geriatr Soc; 2024 Feb; 72(2):410-422. PubMed ID: 38055194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study.
    Agca R; Hopman LHGA; Laan KJC; van Halm VP; Peters MJL; Smulders YM; Dekker JM; Nijpels G; Stehouwer CDA; Voskuyl AE; Boers M; Lems WF; Nurmohamed MT
    J Rheumatol; 2020 Mar; 47(3):316-324. PubMed ID: 31092721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statins After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research Datalink Database.
    Lefeber GJ; Koek HL; Souverein PC; Bouvy ML; de Boer A; Knol W
    J Am Geriatr Soc; 2020 Feb; 68(2):329-336. PubMed ID: 31647578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
    Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statins, risk of diabetes, and implications on outcomes in the general population.
    Wang KL; Liu CJ; Chao TF; Huang CM; Wu CH; Chen SJ; Chen TJ; Lin SJ; Chiang CE
    J Am Coll Cardiol; 2012 Oct; 60(14):1231-8. PubMed ID: 22884288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statin use for primary prevention in patients with type 2 diabetes: Can it benefit all ages? - A nationwide propensity-matched cohort study.
    Jun JE; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    Diabetes Res Clin Pract; 2021 Oct; 180():109044. PubMed ID: 34508736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothyroidism is a Risk Factor for New-Onset Diabetes: A Cohort Study.
    Gronich N; Deftereos SN; Lavi I; Persidis AS; Abernethy DR; Rennert G
    Diabetes Care; 2015 Sep; 38(9):1657-64. PubMed ID: 26070591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.
    Ridker PM; Pradhan A; MacFadyen JG; Libby P; Glynn RJ
    Lancet; 2012 Aug; 380(9841):565-71. PubMed ID: 22883507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of statin on major adverse cardiovascular events and mortality in patients with rheumatoid arthritis - a systematic review and meta-analysis.
    Rahmadi AR; Pranata R; Raffaello WM; Yonas E; Ramadhian MP; Natadikarta MRR; Akbar MR
    Eur Rev Med Pharmacol Sci; 2022 May; 26(9):3171-3178. PubMed ID: 35587067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular (CV) Risk after Initiation of Abatacept versus TNF Inhibitors in Rheumatoid Arthritis Patients with and without Baseline CV Disease.
    Jin Y; Kang EH; Brill G; Desai RJ; Kim SC
    J Rheumatol; 2018 Aug; 45(9):1240-1248. PubMed ID: 29764964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study.
    Kim SC; Glynn RJ; Liu J; Everett BM; Goldfine AB
    Acta Diabetol; 2014 Dec; 51(6):1015-23. PubMed ID: 25311055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.